Daily Aspirin Reduced the Incidence of Hepatocellular Carcinoma and Overall Mortality in Patients with Cirrhosis

Daily Aspirin Reduced the Incidence of Hepatocellular Carcinoma and Overall Mortality in Patients with Cirrhosis

Background: Cirrhosis is the primary risk factor for hepatocellular carcinoma (HCC) and gastrointestinal bleeding (GI). We aimed to assess the efficacy and safety of daily aspirin on HCC occurrence, overall survival, and GI bleeding in cirrhotic patients. Methods: A total of 35,898 eligible cases we...

Full description

Bibliographic Details
Main Authors: Chern-Horng Lee, Chiu-Yi Hsu, Tzung-Hai Yen, Tsung-Han Wu, Ming-Chin Yu, Sen-Yung Hsieh
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Cancers
Subjects:
aspirin
antiplatelet agents
cirrhosis
liver cancer
hepatocellular carcinoma
chemoprevention
Online Access:https://www.mdpi.com/2072-6694/15/11/2946

Internet

https://www.mdpi.com/2072-6694/15/11/2946

Similar Items